Cited by 1,364NF-κB Signaling PathwaysNatural Compounds in Disease TreatmentSignaling Pathways in Disease

The IKK NF-κB system: a treasure trove for drug development

Karin, Michael, Yamamoto, Yumi, Wang, Q. May·2004·Nature Reviews Drug Discovery

Integrity signals

Registry

Crossref · 10.1038/nrd1279

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Karin, M., Yamamoto, Y., & Wang, Q. M.
Affiliations
  • University of California San Diego (US)
  • Eli Lilly (United States) (US)
Corresponding author
  • Karin, Michael
  • Wang, Q. May
Venue
Nature Reviews Drug Discovery
Published
2004-01
Volume
3
Issue
1
Pages
17-26
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W2043892945
Cited by
1,364
References
70
Citations by year
2026: 13 · 2025: 15 · 2024: 25 · 2023: 33 · 2022: 33 · 2021: 36 · 2020: 50 · 2019: 36 · 2018: 41 · 2017: 39 · 2016: 54 · 2015: 55 · 2014: 60 · 2013: 79 · 2012: 74
FWCI
8.98
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Reviews Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
NF-κB, Rel transcription factors, IκB kinase, NF-κB inhibitors, drug development, inflammation, autoimmune disease, cancer, NF-κB signaling
MeSH terms
Adjuvants, Immunologic, Animals, Anti-Inflammatory Agents, Enzyme Inhibitors, Humans, Drug Design, Molecular Structure, Signal Transduction, NF-kappa B, Protein Serine-Threonine Kinases, I-kappa B Kinase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review